Literature DB >> 32744972

An Insight in Pathophysiological Mechanism of Alzheimer's Disease and its Management Using Plant Natural Products.

Zeba Firdaus1, Tryambak Deo Singh1.   

Abstract

Alzheimer's disease (AD) is an age-associated nervous system disorder and a leading cause of dementia worldwide. Clinically, it is described by cognitive impairment and pathophysiologically by deposition of amyloid plaques and neurofibrillary tangles in the brain and neurodegeneration. This article reviews the pathophysiology, course of neuronal degeneration, and the various possible hypothesis of AD progression. These hypotheses include amyloid cascade, tau hyperphosphorylation, cholinergic disruption, metal dysregulation, vascular dysfunction, oxidative stress, and neuroinflammation. There is an exponential increase in the occurrence of AD in the recent few years that indicate an urgent need to develop some effective treatment. Currently, only 2 classes of drugs are available for AD treatment, namely acetylcholinesterase inhibitor and NMDA receptor antagonist. Since AD is a complex neurological disorder and these drugs use a single target approach, alternatives are needed due to limited effectiveness and unpleasant side-effects of these drugs. Currently, plants have been used for drug development research especially because of their multiple sites of action and fewer side effects. Uses of some herbs and phytoconstituents for the management of neuronal disorders like AD have been documented in this article. Phytochemical screening of these plants shows the presence of many beneficial constituents like flavonoids, triterpenes, alkaloids, sterols, polyphenols, and tannins. These compounds show a wide array of pharmacological activities, such as anti-amyloidogenic, anticholinesterase, and antioxidants. This article summarizes the present understanding of AD progression and gathers biochemical evidence from various works on natural products that can be useful in the management of this disease. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Alzheimer's disease (AD); Amyloid-β (Aβ); Medicinal Plants; Neurofibrillary tangles (NFTs); Neuroinflammation; Terpenes

Mesh:

Substances:

Year:  2021        PMID: 32744972     DOI: 10.2174/1389557520666200730155928

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  5 in total

1.  Centella asiatica Alleviates AlCl3-induced Cognitive Impairment, Oxidative Stress, and Neurodegeneration by Modulating Cholinergic Activity and Oxidative Burden in Rat Brain.

Authors:  Zeba Firdaus; Devendra Kumar; Sushil Kumar Singh; Tryambak Deo Singh
Journal:  Biol Trace Elem Res       Date:  2022-01-04       Impact factor: 4.081

2.  Vascular Risk Factors, Imaging, and Outcomes in Transient Ischemic Attack/Ischemic Stroke Patients with Neuroimaging Evidence of Probable/Possible Cerebral Amyloid Angiopathy.

Authors:  Qihui Zhang; Anxin Wang; Xia Meng; Xiaoling Liao; Yijun Zhang; Huiqing Hou; Lijuan Niu; Ruiping Li; Wenjuan Guo; Yongjun Wang
Journal:  Oxid Med Cell Longev       Date:  2021-04-26       Impact factor: 6.543

Review 3.  Antioxidants in Alzheimer's Disease: Current Therapeutic Significance and Future Prospects.

Authors:  Pingal Pritam; Rahul Deka; Anuradha Bhardwaj; Rashi Srivastava; Dhruv Kumar; Abhimanyu Kumar Jha; Niraj Kumar Jha; Chiara Villa; Saurabh Kumar Jha
Journal:  Biology (Basel)       Date:  2022-01-28

4.  Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis.

Authors:  Le-Tian Huang; Cheng-Pu Zhang; Yi-Bing Wang; Jia-He Wang
Journal:  Front Aging Neurosci       Date:  2022-05-06       Impact factor: 5.750

5.  The Analysis of Oxidative Stress Markers May Increase the Accuracy of the Differential Diagnosis of Alzheimer's Disease with and without Depression.

Authors:  Anna Polak-Szabela; Inga Dziembowska; Marietta Bracha; Agnieszka Pedrycz-Wieczorska; Kornelia Kedziora-Kornatowska; Mariusz Kozakiewicz
Journal:  Clin Interv Aging       Date:  2021-06-16       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.